Repackaging of medicine is a hotly debated issue between pharmaceutical companies and parallel traders. Last week the CJEU published its keenly awaited judgments concerning several well-known pharmaceutical companies which provide welcome guidance. Read the article in full on BioTalk here.
| less than a minute read
To repackage or not? Latest CJEU rulings provide guidance for parallel traders of medicines
Get in touch
Get in touch
Get in touch
Get in touch
Latest Insights
/Passle/64ef1c9c95186b4923406017/MediaLibrary/Images/2024-06-20-10-59-02-732-66740b760930b78ca91ec6ed.jpg)
/Passle/64ef1c9c95186b4923406017/MediaLibrary/Images/2024-06-20-11-13-37-628-66740ee1bc343c0c8dbf7a8b.jpg)
/Passle/64ef1c9c95186b4923406017/MediaLibrary/Images/2024-06-20-10-52-01-031-667409d1bc343c0c8dbf6e2a.jpg)
/Passle/64ef1c9c95186b4923406017/MediaLibrary/Images/2024-06-20-10-48-15-709-667408efbc343c0c8dbf6b5f.jpg)